ApoE-functionalization of nanoparticles for targeted brain delivery-a feasible method for polyplexes?

Area of Science:

• Neuroscience
• Biotechnology
• Materials Science

Background:

• The blood-brain barrier (BBB) restricts therapeutic access to the central nervous system (CNS).
• Small interfering RNA (siRNA) holds therapeutic potential for CNS diseases by silencing target genes.
• Effective delivery of nucleic acids across the BBB remains a significant challenge.

Purpose of the Study:

• To investigate ApoE functionalization of siRNA polyplexes for enhanced BBB penetration.
• To evaluate the impact of polysorbate 80 (PS 80) precoating on ApoE binding and delivery.
• To assess the efficacy of ApoE-coated polyplexes in vitro and in vivo.

Main Methods:

• Formation of siRNA polyplexes using branched poly(ethyleneimine) (b-PEI) and nylon-3 polymers.
• Functionalization of polyplexes with Apolipoprotein E (ApoE), with and without PS 80 precoating.
• Evaluation of ApoE binding, cellular uptake in U87 glioma cells, and gene silencing efficacy.
• Assessment of in vivo delivery and therapeutic effect in a relevant animal model.

Main Results:

• Successful ApoE binding was observed on nylon-3 polyplexes, but not on PEI polyplexes, with or without PS 80.
• ApoE-coated nylon-3 polyplexes demonstrated significantly increased cellular uptake and gene silencing in U87 glioma cells.
• No significant therapeutic benefit or BBB penetration enhancement was observed in vivo.

Conclusions:

• ApoE functionalization of nylon-3 polyplexes shows promise for in vitro siRNA delivery across the BBB.
• The in vitro-in vivo translation of ApoE-functionalized polyplexes requires further optimization.
• More advanced in vitro models are needed to better predict in vivo performance for CNS drug delivery.